Silver Book Fact

Moderate or severe aortic valve disease is present in 4.2% to 10.7% of the population ages 65 and older.

Bach D, Radeva J, Birnbaum H, Fournier A, Tuttle E. Prevalence, Referral Patterns, Testing, and Surgery in Aortic Valve Disease: Leaving women and elderly patients behind?. Journal of Heart Valve Disease. 2007; 16(4). https://www.medscape.com/medline/abstract/17702360

Nkomo, Vuyisile, Julius Gardin, Thomas Skelton, John Gottdiener, Christopher Scott, Maurice Enriquez-Sarano. Burden of Valvular Heart Diseases: a population-based study. Lancet. September 2006; 368(9540). http://www.ncbi.nlm.nih.gov/pubmed/16980116

Reference

Title
Prevalence, Referral Patterns, Testing, and Surgery in Aortic Valve Disease: Leaving women and elderly patients behind?
Publication
Journal of Heart Valve Disease
Publication Date
2007
Authors
Bach D, Radeva J, Birnbaum H, Fournier A, Tuttle E
Volume & Issue
Volume 16, Issue 4
URL
Read Full Resource
Title
Burden of Valvular Heart Diseases: a population-based study
Publication
Lancet
Publication Date
September 2006
Authors
Nkomo, Vuyisile, Julius Gardin, Thomas Skelton, John Gottdiener, Christopher Scott, Maurice Enriquez-Sarano
Volume & Issue
Volume 368, Issue 9540
Pages
1005-11
URL
Read Full Resource

Categories

  • Cost of Disease
  • Age - A Major Risk Factor

Related Facts

  • Medicare patients with sSAS have an average lifespan of 1.8 years without repair or replacement
     
  • Aortic valve disease costs
    Aortic valve disease (AVD) (symptomatic and asymptomatic) costs the U.S. $10.2 billion in direct costs each year.  
  • 2016 prevalence of Americans 65+ who had AVD
    In 2016, an estimated 5.2 million U.S. adults ages 65+ had aortic valve disease (AVD).   Note: Alliance for Aging Research generated statistic, based on 2005 percentage prevalence estimates by Bach et al. 2007  
  • All-cause mortality for aortic valve disorders
    In 2014, all-cause mortality for aortic valve disorders was 34,408 in the U.S.  
  • 1 and 6-month mortality rates without treatment for sSAS
    Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).